title: Effects of inulin on faecal bifidobacteria in human subjects.
abstract: A controlled study with eight healthy free-living subjects was carried out, in which energy intake was adjusted to the individual energy requirements. On administration of inulin, blood lipids, the faecal microflora, short-chain fatty acids and accompanying gastrointestinal symptoms were characterized in order to investigate the long-term effect of inulin. During the run-in phase (8 d), subjects received a typical Western diet providing 45% energy as fat and 40% energy as carbohydrate. Subsequently, the subjects consumed a fat-reduced diet which provided 30% energy as fat and 55% energy as carbohydrate for a period of 64 d using inulin as a fat replacer. The amounts of inulin consumed by the subjects (up to 34 g/d) were based on individual energy requirements with the aim to keep the diet isoenergetic with that used in the run-in period. To assess the effects of inulin administration, a control study (run-in and intervention) was carried out in which subjects consumed the same diet but devoid of inulin during the whole course of the study. To investigate the effect of inulin on faecal flora composition total bacteria and bifidobacteria in the faeces were enumerated by in situ hybridization with 16S rRNA targeted oligonucleotide probes. Inulin significantly increased bifidobacteria from 9.8 to 11.0 log10/g dry faeces and caused a moderate increase in gastrointestinal symptoms such as flatulence and bloatedness, whereas blood lipids and short-chain fatty acids remained essentially unaffected.
authors.affiliation: University of Potsdam, Institute of Nutritional Science, Bergholz-Rehbruecke, Germany. kruse@www.dife.de
authors.forename: H P
authors.initials: HP
authors.lastname: Kruse
authors.forename: B
authors.initials: B
authors.lastname: Kleessen
authors.forename: M
authors.initials: M
authors.lastname: Blaut
mesh_terms: D000328:Adult; D000704:Analysis of Variance; D001644:Bifidobacterium / Q000187:drug effects* / Q000302:isolation & purification / Q000378:metabolism; D002784:Cholesterol / Q000097:blood; D003106:Colon / Q000382:microbiology; D015169:Colony Count, Microbial; D004041:Dietary Fats / Q000008:administration & dosage*; D004734:Energy Metabolism; D005232:Fatty Acids, Volatile / Q000032:analysis; D005243:Feces / Q000737:chemistry / Q000382:microbiology*; D005260:Female; D005414:Flatulence / Q000139:chemically induced; D006801:Humans; D007444:Inulin / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D018709:Statistics, Nonparametric; D014280:Triglycerides / Q000097:blood
chemical_list: D004041:Dietary Fats; D005232:Fatty Acids, Volatile; D014280:Triglycerides; D007444:Inulin; D002784:Cholesterol